Team
Our Team
We believe in the importance of a cohesive and experienced team that genuinely enjoy working together and the thrill of breaking new ground that can change the way we treat cancer.
Team Members
Add an additional text description here.
Fotis
Asimakopoulos
MB, BChir, PhD
Add an additional text description here.
Athanasios (Thanos) Papadas
MD, PhD
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent maximus iaculis libero, nec tincidunt nibh tincidunt vitae. In euismod purus vitae eros pharetra bibendum. Nam ut sodales purus. Sed magna augue, gravida ac felis et, ultricies sagittis neque. Praesent condimentum mi scelerisque massa hendrerit, eleifend pharetra lacus sagittis. Integer molestie magna dignissim, aliquam erat non, elementum nisl. Etiam tristique odio urna, eu tincidunt justo mattis ac. Duis eu ultricies risus, quis convallis felis. Aenean sapien lacus, porttitor vel condimentum quis, euismod sit amet tortor. Quisque auctor mollis mi sollicitudin sollicitudin. Vivamus eleifend, tortor pharetra bibendum cursus, ante erat dignissim tortor, in varius massa purus ac odio. Aliquam erat volutpat. Curabitur tristique, nisi vitae sagittis commodo, massa augue sollicitudin leo, eget viverra enim nisl ac felis.
Vivamus id sagittis purus. Ut ut bibendum sapien. Aliquam ultricies dapibus velit, malesuada luctus metus ultrices et. Morbi elit enim, condimentum vitae ex ac, consequat commodo ante. Cras lacus velit, fermentum sed leo vitae, iaculis consectetur arcu. Vivamus pulvinar ultrices tincidunt. Integer convallis blandit fringilla. Mauris dictum, ipsum ut hendrerit varius, odio risus fermentum magna, aliquet sagittis massa arcu in lorem. Morbi dignissim lacinia suscipit.
Vivamus id sagittis purus. Ut ut bibendum sapien. Aliquam ultricies dapibus velit, malesuada luctus metus ultrices et. Morbi elit enim, condimentum vitae ex ac, consequat commodo ante. Cras lacus velit, fermentum sed leo vitae, iaculis consectetur arcu. Vivamus pulvinar ultrices tincidunt. Integer convallis blandit fringilla. Mauris dictum, ipsum ut hendrerit varius, odio risus fermentum magna, aliquet sagittis massa arcu in lorem. Morbi dignissim lacinia suscipit.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent maximus iaculis libero, nec tincidunt nibh tincidunt vitae. In euismod purus vitae eros pharetra bibendum. Nam ut sodales purus. Sed magna augue, gravida ac felis et, ultricies sagittis neque. Praesent condimentum mi scelerisque massa hendrerit, eleifend pharetra lacus sagittis. Integer molestie magna dignissim, aliquam erat non, elementum nisl. Etiam tristique odio urna, eu tincidunt justo mattis ac. Duis eu ultricies risus, quis convallis felis. Aenean sapien lacus, porttitor vel condimentum quis, euismod sit amet tortor. Quisque auctor mollis mi sollicitudin sollicitudin. Vivamus eleifend, tortor pharetra bibendum cursus, ante erat dignissim tortor, in varius massa purus ac odio. Aliquam erat volutpat. Curabitur tristique, nisi vitae sagittis commodo, massa augue sollicitudin leo, eget viverra enim nisl ac felis.
Vivamus id sagittis purus. Ut ut bibendum sapien. Aliquam ultricies dapibus velit, malesuada luctus metus ultrices et. Morbi elit enim, condimentum vitae ex ac, consequat commodo ante. Cras lacus velit, fermentum sed leo vitae, iaculis consectetur arcu. Vivamus pulvinar ultrices tincidunt. Integer convallis blandit fringilla. Mauris dictum, ipsum ut hendrerit varius, odio risus fermentum magna, aliquet sagittis massa arcu in lorem. Morbi dignissim lacinia suscipit.
Vivamus id sagittis purus. Ut ut bibendum sapien. Aliquam ultricies dapibus velit, malesuada luctus metus ultrices et. Morbi elit enim, condimentum vitae ex ac, consequat commodo ante. Cras lacus velit, fermentum sed leo vitae, iaculis consectetur arcu. Vivamus pulvinar ultrices tincidunt. Integer convallis blandit fringilla. Mauris dictum, ipsum ut hendrerit varius, odio risus fermentum magna, aliquet sagittis massa arcu in lorem. Morbi dignissim lacinia suscipit.
Add an additional text description here.
Alexander
Cicala
Inspired by the opportunity to develop transformative medicines for patients.
Kevin
Lyncha
MB, BS
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent maximus iaculis libero, nec tincidunt nibh tincidunt vitae. In euismod purus vitae eros pharetra bibendum. Nam ut sodales purus. Sed magna augue, gravida ac felis et, ultricies sagittis neque. Praesent condimentum mi scelerisque massa hendrerit, eleifend pharetra lacus sagittis. Integer molestie magna dignissim, aliquam erat non, elementum nisl. Etiam tristique odio urna, eu tincidunt justo mattis ac. Duis eu ultricies risus, quis convallis felis. Aenean sapien lacus, porttitor vel condimentum quis, euismod sit amet tortor. Quisque auctor mollis mi sollicitudin sollicitudin. Vivamus eleifend, tortor pharetra bibendum cursus, ante erat dignissim tortor, in varius massa purus ac odio. Aliquam erat volutpat. Curabitur tristique, nisi vitae sagittis commodo, massa augue sollicitudin leo, eget viverra enim nisl ac felis.
Vivamus id sagittis purus. Ut ut bibendum sapien. Aliquam ultricies dapibus velit, malesuada luctus metus ultrices et. Morbi elit enim, condimentum vitae ex ac, consequat commodo ante. Cras lacus velit, fermentum sed leo vitae, iaculis consectetur arcu. Vivamus pulvinar ultrices tincidunt. Integer convallis blandit fringilla. Mauris dictum, ipsum ut hendrerit varius, odio risus fermentum magna, aliquet sagittis massa arcu in lorem. Morbi dignissim lacinia suscipit.
Vivamus id sagittis purus. Ut ut bibendum sapien. Aliquam ultricies dapibus velit, malesuada luctus metus ultrices et. Morbi elit enim, condimentum vitae ex ac, consequat commodo ante. Cras lacus velit, fermentum sed leo vitae, iaculis consectetur arcu. Vivamus pulvinar ultrices tincidunt. Integer convallis blandit fringilla. Mauris dictum, ipsum ut hendrerit varius, odio risus fermentum magna, aliquet sagittis massa arcu in lorem. Morbi dignissim lacinia suscipit.
Kevin Lynch, MB, BS. is inspired by the opportunity to develop transformative medicines for patients.
He has lived and worked in Australia, Asia, UK, and Switzerland, operating in both small, start-up environments as well as large, multi-nationals.
Kevin was Chief Medical Expert during Antengene’s formative years and then through a period of extreme growth as Chief Medical Officer. He supervised their broad clinical program with Xpovio (Selinexor) in Asia-Pacific, as well as an extensive first-in-human early development program.
During over 11 years at Celgene Kevin was closely involved in the successful clinical development and registration of Revlimid (lenalidomide), Pomalyst (pomalidomide), Vidaza (azacitidine), Onureg (oral azacitidine) and Idhifa (enasidinib).
During his 10 years with Novartis, as one of the inaugural Oncology Medical Directors for the company, he played a key role in the development and approvals of multiple transformative drugs including Glivec (imatinib), Tasigna (nilotinib), Zometa (zoledronic acid), Femara (letrozole) and Exjade (deferasirox).
Kevin graduated B Med Sci and MB, BS from the University of Tasmania in Australia. His post-graduate training in Pharmaceutical Medicine was completed in the UK, where he gained his Fellowship of the Faculty of Pharmaceutical Medicine.
Passionate about advancing innovative science for the benefit of patients.
Peter
Greaney
PhD
Thrives on building teams and creating collaborative impact.
Gertjan
Bartlema
Peter Greaney, PhD. is a global deal-maker and is passionate about advancing innovative science for the benefit of patients.
Peter has international experience in building successful biotech companies. He has been responsible for the successful execution of numerous business development deals in his career and has experience in a wide array of deal structures. He is experienced in seeking new business opportunities, leading negotiations, and managing research collaborations.
At ADC Therapeutics, Peter was the Head of Corporate Development and played an integral role transforming the company from a private R&D biotech to a NYSE listed public biotech with a commercial therapeutic product. Prior to ADC Therapeutics, Peter held medical and business positions of increasing responsibility at Celgene in Switzerland and the United States. He held roles in Business Development, Strategy & Operations, Market Research & Business Intelligence, Medical Affairs, and Medical Development.
Prior to Celgene, Peter was a Preclinical Senior Scientist at Apoxis, S.A. in Switzerland and an intern scientist at Servier, Paris.
Peter graduated with a Bachelor of Science in Cell Biology from the University of East Anglia and a PhD in Molecular and Cellular Biology from the University of Nottingham (supported by Servier).
Gertjan Bartlema, thrives on building teams and creating collaborative impact. He is a pragmatic and authentic leader with broad operational biotech experience.
Gertjan was the CEO of VICO Therapeutics BV a privately held Netherlands based company focused on antisense oligonucleotide-based RNA modulating therapeutics for rare CNS diseases.
During his 20+ years global biotech career he was part of emerging organizations and new capability building, including healthcare big data/real-world data and marketing & sales excellence capabilities. During his 12 years at Celgene (US and Switzerland), he was part of the European management team, the corporate business development team that acquired Abraxis and the information knowledge utilization team that established an industry leading network of real-world data and technology partnerships including COTA, Inc., Flatiron Health, and GNS Healthcare and strategic partnerships with IBM Watson, Health2047, and M2Gen.
Other roles he held during his career include Strategy, Marketing & Sales Excellence, Business Planning and Financial Planning & Analysis. He started his biotech career at Amgen Europe based in Lucerne, Switzerland. Over a nine-year period at Amgen he was based in Thousand Oaks, CA and Switzerland.
Gertjan holds a Masters in Economics from Maastricht University, the Netherlands and was an ERASMUS student at Bern University, Switzerland. He holds dual Dutch and Swiss citizenship. He lives with his family in Switzerland.